Abstract
To describe the disease characteristics in Chinese adult patients with psoriasis receiving interleukin-17A (IL-17A) inhibitors in a tertiary care clinic in Changsha, China.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
